Martinus J.K. Ankone
University of Twente
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Martinus J.K. Ankone.
Eurointervention | 2009
M.Z. Basalus; Martinus J.K. Ankone; K.G. van Houwelingen; F.H. de Man; Clemens von Birgelen
AIMSnTo classify and quantify post-expansion irregularities in durable polymer-based coatings of drug-eluting stents (DES).nnnMETHODS AND RESULTSnTaxus Liberté, Endeavor Sprint, Endeavor Resolute and Xience V DES (three samples of each) were explored by light microscopy and scanning electron microscopy (SEM) following expansion at 14 atm in water. Incidence and size of irregularities were measured during thorough quantitative examinations of a 360 SEM images. DES types examined showed a significant difference in the incidence of irregularities (p<0.0001; 6.6+/-4.2/image at 60-fold magnification) with typical patterns specific for each DES. All types showed areas with bare metal-aspects, but incidence, shape, and size differed largely: Sprint showed the largest areas. Cracks were only found in Sprint and Resolute, while wrinkles were seen exclusively in Taxus Liberté and Xience V (p<0.0001). The coating of each DES type showed some inhomogeneity of distribution, but the incidence differed (p<0.0001) and was least in Taxus Liberté, which, on the other hand, was the only DES that showed webbing with large bare-metal exposure.nnnCONCLUSIONSnThe incidence and size of various coating irregularities on different types of DES varied widely. These data may be considered in ongoing discussions on the differences between DES and may serve as reference to compare novel DES.
Eurointervention | 2010
M.Z. Basalus; K.G. van Houwelingen; Martinus J.K. Ankone; Jan Feijen; Clemens von Birgelen
Aims: To assess the spatial geometry of drug-eluting stents (DES) following extremely oversized proximal postdilatation. Interventions of distal left main (LM) disease generally require stenting across the LM bifurcation with inherent vessel tapering along this segment and a high likelihood of stent malapposition, which can be avoided by such postdilations. Methods and results: Sixteen DES (four 3.5 mm-samples of Cypher Select Plus, Taxus Liberte, Endeavor Resolute, Xience V) were deployed in water; 12 samples were then proximally postdilated with noncompliant 5.0 mm balloons at 18 atm. All samples were examined by micro-computed tomography. Taxus Liberte, Endeavor Resolute, and Xience V, showed increased cell areas in the transitional region (just distal to postdilated region), while Cypher Select showed its largest cells inside the postdilated region. Overall, the largest maximum cell area was observed in Endeavor Resolute, while Cypher Select showed the smallest (p<0.001, for both). In addition, the size of the very proximal postdilated cells was relatively small in most DES except Xience V. Conclusions: Extremely oversized partial stent postdilatation demonstrated significant between-DES differences in final spatial stent configuration and maximum cell size. These data could be of practical interest with regard to coronary interventions in LM stems with stenting across the LM bifurcation.
Journal of Controlled Release | 2013
Martin Piest; Martinus J.K. Ankone; Johannes F.J. Engbersen
In order to evaluate the influence of incorporation of boronic acid groups on the properties of poly(amido amine)s as gene vectors, a novel poly(amido amine) copolymer p(CBA-ABOL/2AMPBA) containing ortho-aminomethylphenylboronic acid (2AMPBA) moieties was prepared by Michael-type polyaddition of a mixture of 1,4-aminobutanol (ABOL) and 2-((4-aminobutylamino)methyl)phenyl boronic acid to N,N-cystamine bisacrylamide (CBA). It appeared that the presence of the boronic acid moieties as side groups along the polymer chain strongly enhances the stability of the self-assembled nanoparticles and nanosized polyplexes formed from this polymer; no aggregation was observed after storage for 6days at 37°C. This strong stabilization can be attributed to intermolecular Lewis acid-base interactions between the 2AMPBA groups and the alcohol and amine groups present in the polymer, leading to dynamical (reversible) crosslinking in the nanoparticles. Moreover, since the boronic acids can reversibly form boronic esters with vicinal diol groups, the presence of the 2AMPBA groups add carbohydrate-interactive properties to these polymers that strongly influence their behavior as gene delivery vectors. DNA transfection with p(CBA-ABOL/2AMPBA) polyplexes gave transfection efficiencies that were approximately similar to commercial PEI in different cell lines (COS-7, HUH-6 and H1299-Fluc), but lower than those obtained with reference polyplexes from p(CBA-ABOL). It is hypothesized that the uptake of the boronated polyplexes is suppressed by binding to the glycocalyx of the cells. This is supported by the observation that addition of sorbitol or dextran to the transfection medium significantly enhances the transfection efficiency, which can be attributed to increased cellular uptake of the polyplexes due to boronic ester formation with these agents. AFM, SEM and confocal microscopy showed that polyplexes of p(CBA-ABOL/2AMPBA) become decorated with a dextran layer in the presence of 0.9% (w/v) dextran in the polyplex medium. In siRNA-mediated gene silencing experiments the use of p(CBA-ABOL/2AMPBA) as polymeric vector gave a knockdown of luciferase expression in H1229-Fluc cells of 35%. Also in this case addition of 0.9% (w/v) sorbitol or dextran to the transfection medium strongly increased the knockdown efficiency to 59% and 76%, respectively.
Journal of Controlled Release | 1996
C.J.T. Hoes; Martinus J.K. Ankone; J. Grootoonk; Jan Feijen; E. van der Struik; A. van Doornmalen; Diep T. Pham; A. de Man; A. van Ettekoven; I. Schlachter; P.J. Boon; Frans M. Kaspersen; Ebo Bos
The synthesis and purification of radiolabelled immunoconjugates, composed of a human IgM monoclonal antibody (IgM 16.88) directed against an intracellular tumour-associated antigen, the drug carrier poly[N5-(2-hydroxyethyl)--glutamine] (PHEG) and the cytostatic drug adriamycin (ADR) are described. The immunoconjugates were constructed to allow selective release of ADR in the putatively acidic environment of the tumour through a novel acid-labile maleamic acid linker. The conjugate of PHEG and the acid-labile ADR derivative effectively released ADR in cytotoxic amounts at a pH of 6.0 as judged from incubation in buffer and from inhibition of the growth of HT-29 colon tumour cells in vitro. Immunoconjugates were prepared by coupling of PHEG-ADR having a hydrolytically stable amide bond with 131I-labelled antibody through thioether bond formation involving a single thiol group at the C-terminus of the polymer chain and maleimido groups introduced onto the
Macromolecular Bioscience | 2016
Young-Wook Won; Martinus J.K. Ankone; Johannes F.J. Engbersen; Jan Feijen; Sung Wan Kim
A new type of bioreducible poly(amido amine) copolymer is synthesized by the Michael addition polymerization of cystamine bisacrylamide (CBA) with 4-aminobutylguanidine (agmatine, AGM) and 4-aminobutanol (ABOL). Since the positively charged guanidinium groups of AGM and the hydroxybutyl groups of ABOL in the side chains have shown to improve the overall transfection efficiency of poly(amido amine)s, it is hypothesized that poly(CBA-ABOL/AGM) synthesized at the optimal ratio of both components would result in high transfection efficiency and minimal toxicity. In this study, a series of the poly(CBA-ABOL/AGM) copolymers is synthesized as gene carriers. The polymers are characterized and luciferase transfection efficiencies of the polymers in various cell lines are investigated to select the ideal ratio between AGM and ABOL. The poly(CBA-ABOL/AGM) containing 80% AGM and 20% ABOL has shown the best transfection efficiency with the lowest cytotoxicity, indicating that this polymer is very promising as a potent and nontoxic gene carrier.
Interventional Cardiology | 2011
Mounir W.Z. Basalus; K. Tandjung; Aart A. van Apeldoorn; Martinus J.K. Ankone; Clemens von Birgelen
Archive | 2010
M.Z. Basalus; K. Tandjung; Aart A. van Apeldoorn; Martinus J.K. Ankone; P.K.N. van der Jagt; G.J. Pelgrim; Clemens von Birgelen
NVVC Scientific Spring Meeting 2010 | 2010
Mounir W.Z. Basalus; K. Tandjung; A.A. van Apeldoorn; Martinus J.K. Ankone; P.K.N. van der Jagt; G.J. Pelgrim; C. von Birgelen
Symposium Highlights in Biomedical Technology 2008 | 2008
M.Z. Basalus; Martinus J.K. Ankone; K.G. van Houwelingen; Martin G. Stoel; P. W. Serruys; Jan Feijen; Clemens von Birgelen
8th Dutch Annual Conference on BioMedical Engineering, 2001 | 2002
Jan Feijen; P.A.M. Lips; W.M.G.F. Pontenagel; Martinus J.K. Ankone; Pieter J. Dijkstra